Teva anuncia el lanzamiento en Estados Unidos de primera versión genérica de aerosol nasal para tratar emergencia de opioides - enFarma
Takeda and Frazier team up to launch Phathom Pharmaceuticals
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry | Annals of the Rheumatic Diseases
Alvotech y Teva acuerdan conciliación y licencia con Johnson & Johnson para su biosimilar - enFarma
Frontiers | Left ventricular systolic function in subjects conceived through assisted reproductive technologies
Takeda to divest select OTC products to STADA for $660m
Theramex y Enzene Biosciences firman acuerdo para desarrollar y comercializar un tratamiento para artritis reumatoide - enFarma
Teva México relanza su marca y anuncia visión estratégica - enFarma
Levonorgestrel Market Study & Analysis By, 2030
Analyzing Levonorgestrel Market Trends in 2023: Growth Dynamics, Segmentation, Future Demands, Innovations, Regional Sales Projection by 2030
UNITED NATIONS GLOBAL COMPACT COMMUNICATION ON PROGRESS
Productos - Laboratorio Chile | Teva
Accord Healthcare su LinkedIn: #comunicazioneitaliana #forumsostenibilità23 #forumsostenibilità23
levonorgestrel Market CAGR at 6.61% with Future Demand, Market Analysis & Outlook up to 2030
Teva y MedinCell anuncian aprobación de la FDA para su tratamiento para esquizofrenia en adultos - enFarma
Coronavirus antibodies explored by Vir Biotechnology, NIH and Biogen.
Theramex - Overview, News & Competitors | ZoomInfo.com
Four pharma firms accused of anti-competitive practices in UK
UNITED NATIONS GLOBAL COMPACT COMMUNICATION ON PROGRESS
Teva concludes $703m women's health products deal with CVC Capital - Pharmaceutical Technology
Antiemetics And Antinauseants Market Size, Segments Analysis, Forecast 2032
Oral Contraceptive Pills Market Analyis, Share, Drivers And Outlook To 2032
Teva Pharmaceuticals by Aviva Gonter on Prezi Next
Osteoporosis Drugs Market Size, Share | CAGR Of 3.5%
